ANTIHISTAMINE WARNING STATEMENT ON USE IN ASTHMA PATIENTS SHOULD BE DELETED "AS SOON AS POSSIBLE," FDA’s PULMONARY-ALLERGY COMMITTEE CONCLUDES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".